Atlas Trials

Clinical Study to Evaluate Effect on QT/QTc Interval After Multiple Dose of Celecoxib

Clinical trial NCT03822520 · COMPLETED

Trial details

NCT number
NCT03822520
Sponsor
Samsung Medical Center
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Qt Interval, Variation in
Start date
2017-06-30
Primary completion
2018-05-25
Enrollment
28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.